Analyzing and monitoring real-world clinical safety of ensartinib for the treatment of patients with ALK-positive non-small cell lung cancer Journal of International Oncology . 2023, (3): 150 -156 . DOI: 10.3760/cma.j.cn371439-20221230-00030